Family Medicine Doctors in Richmond, MO Accepting Medicare

5 Family Medicine doctors found. Showing 1 - 5

Dr. Whitnee Amaris Maycock, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 902 Wollard Blvd, Richmond, MO 64085 Phone: 816-776-2201

Kourtney Halford, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 420 Wollard Blvd, Richmond, MO 64085 Phone: 816-470-2131

Dr. C Mark Rose, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 902 Wollard Blvd, Richmond, MO 64085 Phone: 816-776-2201    Fax: 816-480-4515

Dr. Melissa Bradley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 902 Wollard Blvd, Richmond, MO 64085 Phone: 402-559-7249

Thomas Phillips Jr., MD Family Medicine Medicare: Medicare Enrolled Practice Location: 902 Wollard Blvd, Richmond, MO 64085 Phone: 816-776-2201    Fax: 816-776-7879

News Archive

Novation, MedLearn enter agreement to provide unsurpassed coding, reimbursement expertise to health care organizations

Novation and MedLearn have entered into a three-year service provider agreement to bring coding, compliance and reimbursement expertise to health care organizations across the country, the two companies announced today.

Prestige Brands agrees to acquire Blacksmith Brands stock for $190 million

Prestige Brands Holdings, Inc., a leading marketer of branded consumer products, today announced that it has entered into a definitive agreement to acquire 100% of the stock of Blacksmith Brands Holdings, Inc., for $190 million in cash.

ITM scientists to combat tapeworm infection using drugs

The Institute of Tropical Medicine Antwerp increases its fight in Congo against the pork tapeworm, in spite of its name also a human parasite, causing epilepsy.

Treating Americans with untested Ebola drug raises concerns

Using the experimental drug before it is tested in clinical trials will make it difficult to determine whether it is actually safe and effective, say scientists. Meanwhile, African officials say they have been inundated with requests from dying patients and their relatives for the same treatment.

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases ("The Liver Meeting").

Read more Medical News

› Verified 3 days ago